Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). (Q33401383)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301).	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase III clinical trial

0 references

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

clinical oncology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Toshiyuki Sawa

7

0 references

author name string

Shinji Atagi

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Masaaki Kawahara

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Akira Yokoyama

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hiroaki Okamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nobuyuki Yamamoto

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yuichiro Ohe

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Satoshi Ishikura

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Taro Shibata

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Haruhiko Fukuda

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nagahiro Saijo

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Tomohide Tamura

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Japan Clinical Oncology Group Lung Cancer Study Group

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

22 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

671-678

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of daily low-dose carboplatin and thoracic radiotherapy in elderly patients with locally advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A case for geriatric oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of radiation-induced cell kill by platinum complexes (carboplatin and iproplatin) in V79 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non-small-cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiotherapy in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970139-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(12)70139-0

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33401383&oldid=1568152497"